CannBioRx Life Sciences C...
(ATNFW)
undefined
undefined%
At close: undefined
0.01
0.00%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | - | - | - | - | - | - | - |
| Cost of Revenue | 105.67K | 109.00K | 116.30K | 125.33K | 72.24K | - | - |
| Gross Profit | -105.67K | -109.00K | -116.30K | -125.33K | -72.24K | - | - |
| Operating Income | -13.48M | -17.90M | -15.64M | -5.65M | -20.86M | -8.74M | -343.88K |
| Interest Income | - | 26.67K | 186.21K | 1.09M | 181.41K | 12.23K | 663.02K |
| Pretax Income | -22.28M | -39.67M | -20.35M | -10.90M | -25.40M | -14.50M | 319.13K |
| Net Income | -19.94M | -38.73M | -20.32M | -12.01M | -25.39M | -14.50M | 123.76K |
| Selling & General & Admin | 10.69M | 15.47M | 11.69M | 3.36M | 18.85M | 7.67M | 343.88K |
| Research & Development | 2.78M | 2.43M | 3.95M | 2.29M | 2.04M | 1.07M | - |
| Other Expenses | - | 246.34B | 770.60K | 264.74K | 250.40K | - | - |
| Operating Expenses | 13.48M | 39.64M | 20.16M | 9.82M | 25.22M | 14.51M | 343.88K |
| Interest Expense | 44.83 | 26.67K | 186.21K | 1.09M | 185.14K | - | - |
| Selling & Marketing Expenses | - | - | - | 38.83K | 12.96M | - | - |
| Cost & Expenses | 13.48M | 39.64M | 20.16M | 9.82M | 25.22M | 14.51M | 343.88K |
| Income Tax | -2.35M | 942.75K | 23.20K | 20.43K | 9.50K | -1 | 195.37K |
| Shares Outstanding (Basic) | 379.00K | 100.00K | 82.00K | 47.00K | 29.00K | 10.00K | 10.00K |
| Shares Outstanding (Diluted) | 379.09K | 100.02K | 82.51K | 47.77K | 29.04K | 10.00K | 10.00K |
| EPS (Basic) | -52.6 | -387.26 | -247.86 | -255.46 | -875.66 | -1.45K | 12.38 |
| EPS (Diluted) | -52.59 | -387.18 | -246.32 | -251.32 | -874.45 | -1.45K | 12.38 |
| EBITDA | -22.13M | -17.79M | -20.05M | -5.52M | -20.79M | -8.72M | -343.88K |
| Depreciation & Amortization | 105.67K | 109.00K | 116.30K | 125.33K | 72.24K | 23.08K | 52.52K |